Study guide

19.1 Accreditation & Inspection Standards

FACHE Board of Governors Exam in Healthcare Management Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the FACHE Credential 1.2 Current Exam Facts 1.3 Eligibility, Application & Recertification

2 Healthcare Systems & Trends

2.1 Healthcare and Medical Terminology 2.2 Healthcare Trends 2.3 Continuum of Care Levels

3 Healthcare Organizations & Services

3.1 Levels of Service from a Business Perspective 3.2 Types of Healthcare Organizations 3.3 Ancillary and Support Services

4 Integration, Clinicians & Staff Perspectives

4.1 Integration, Competition & Partnerships 4.2 Clinician Roles and Qualifying Criteria 4.3 Staff Perspectives & Evidence-Based Management

5 Patient Perspective & Care Delivery

5.1 Patient vs Provider Perspective 5.2 Access, Quality, Cost & Community 5.3 Care Delivery Models and Access Points

6 Digital Health, Population Health & Prevention

6.1 Digital Health 6.2 Population Health Concepts 6.3 Social Determinants & Preventative Medicine

7 Management Planning & Organizational Systems

7.1 Implementation Planning 7.2 Emergency Preparedness & NIMS 7.3 Organizational Systems & Management Functions

8 Leadership, Teams & Change

8.1 Leadership and Communication Styles 8.2 Team-Building Techniques 8.3 Change Management & Organizational Development

9 Collaboration, DEIJ & Networks

9.1 Stakeholder Collaboration 9.2 DEIJ & Resource Allocation 9.3 Network Structures & Collective Bargaining

10 Financial Accounting & Budgeting

10.1 Financial Accounting and Ratios 10.2 Operating Budgets 10.3 Capital Budgeting

11 Reimbursement, Productivity & Controls

11.1 Reimbursement Methodologies 11.2 Productivity Measures 11.3 Financial Controls

12 Revenue, Business Cases & Capital Finance

12.1 Revenue Generation and Payer Mix 12.2 Business Cases & Financial Decision Impacts 12.3 Asset Management & Financing

13 Philanthropy, Supply Chain & Revenue Cycle

13.1 Philanthropy and Foundations 13.2 Supply Chain Management 13.3 Revenue Cycle

14 HR Laws, Recruitment & Staffing

14.1 HR Laws and Regulations 14.2 Recruitment and Retention 14.3 Staffing Methodologies

15 Performance, Engagement & Compensation

15.1 Performance Management Systems 15.2 Motivation, Development & Engagement 15.3 Compensation and Benefits

16 Workplace Safety, Conflict & Labor Relations

16.1 Employee Safety, Security & Health 16.2 Conflict, Grievances & Selection 16.3 Labor Relations & HR Decision Impacts

17 Job Design, Succession & Coaching

17.1 Job Design 17.2 Succession Planning, Mentorship & Coaching

18 Confidentiality, Compliance & Payment Rules

18.1 Confidentiality and Privacy Laws 18.2 Healthcare Compliance Laws 18.3 Medicare, Medicaid & Third-Party Payment Regulations

19 Accreditation, Patient Rights & Ownership Rules

19.1 Accreditation & Inspection Standards 19.2 Patients' Rights Laws 19.3 Nonprofit vs For-Profit Requirements

20 Regulatory Impacts, Labor Law & M&A

20.1 Regulatory Impact on Executive Decisions 20.2 Collective Bargaining Laws 20.3 Legal Implications of Mergers & Acquisitions

21 Benchmarking, Peer Review & Risk

21.1 Benchmarking & Best Practices 21.2 Medical Staff Peer Review 21.3 Risk Management Programs

22 Improvement Methods & Measurement

22.1 PDSA, Lean & Six Sigma 22.2 Clinical Performance Improvement & Pathways 22.3 Quality Measurement & HCAHPS

23 Utilization, Patient Safety & Quality Impacts

23.1 Utilization Review & Case Management 23.2 Patient Safety Tools 23.3 How Quality Impacts Operations

24 Strategic Planning, Business Planning & Contracts

24.1 Strategic Planning Process 24.2 Business Planning for Services 24.3 Business Contracts

25 Socioeconomic Context, Marketing & Media

25.1 Socioeconomic Environment 25.2 Marketing Principles 25.3 Media, Social Media & Community Relations

26 Negotiation & Business Decision Impacts

26.1 Contract Negotiation 26.2 Business Decision Impacts

27 Health IT Operations, Trends & Regulation

27.1 IT in Business Operations 27.2 Technology Trends & Clinical Applications 27.3 HIPAA Security, HITECH & Interoperability

28 Informatics, IT Impacts & Continuity

28.1 Health Informatics for Operational Decisions 28.2 IT Decision Impacts 28.3 Information Systems Continuity

29 IT Acquisition & Analytics

29.1 IT Selection, Acquisition & Maintenance 29.2 Healthcare Analytics & Clinical Informatics

30 ACHE Ethics, Patient Rights & Ethics Committees

30.1 ACHE Code of Ethics 30.2 Patients' Rights & Responsibilities 30.3 Ethics Committees

31 Diversity, Conflicts of Interest & Research Ethics

31.1 Cultural & Spiritual Diversity 31.2 Conflict of Interest 31.3 Unethical Actions & Human-Subject Research

32 Professional Norms, Ethical Culture & Diversity Statement

32.1 Professional Norms & Standards 32.2 Creating an Ethical Culture 32.3 ACHE Statement on Diversity

33 Governance Theory, Structure & Medical Staff

33.1 Governance Theory 33.2 Governance Structure & Operations 33.3 Medical Staff Structure

34 Board Accountability & Public Policy

34.1 Board Role, Accountability & Fiduciary Duty 34.2 Public Policy & Advocacy

19.1 Accreditation & Inspection Standards

Key Takeaways Explain This Topic AI

Licensure, Medicare certification (CoPs), and accreditation are distinct authorities; deemed status helps with CMS survey pathways but never replaces state licensure or other agency oversight.

OSHA enforces workplace safety (bloodborne pathogens, hazard communication, violence-related hazards, PPE, training)—worker safety is both a legal duty and a retention/cost strategy.

FDA interfaces include drugs, devices, biologics/blood, recalls, and medical device reporting; executives own escalation, accountability, and timely response systems.

NRC/Agreement State licenses govern radioactive materials programs (RSO, monitoring, source security, reporting); radiation control is a continuous license condition, not a one-time setup.

CDC guidance often becomes operationally binding through CMS, state rules, accreditors, and standards of care—leaders need a formal process to convert guidance into policy and evidence.

Last updated: August 2026

Accreditation & Inspection Standards

Quick Answer: FACHE-level competence on accreditation and inspection means executives can distinguish licensure from accreditation , prepare the organization for CMS Conditions of Participation and deemed status , and manage multi-agency oversight (OSHA, FDA, NRC, CDC guidance, state survey, and accrediting bodies) as an integrated risk and quality system—not as disconnected “visit weeks.”

Healthcare organizations operate under a dense web of licensure, certification, accreditation, and inspection . For executives, the management problem is not memorizing every standard number; it is designing governance, accountability, and continuous readiness so that patient safety, workforce protection, and legal authority to operate never depend on last-minute scrubbing before a surveyor arrives.

Licensure, Certification, Accreditation: Different Authorities

State licensure is typically the legal permission to operate a hospital, nursing facility, ambulatory surgery center, home health agency, or other licensed setting. Without a license (or an equivalent statutory authorization), the organization generally cannot lawfully provide regulated services. Licensure is enforced by state health departments or boards and can include facility standards, staffing minimums, physical plant rules, incident reporting, and intermediate sanctions up to license suspension or revocation.

Medicare certification (and Medicaid participation) is a federal pathway tied to Conditions of Participation (CoPs) or Conditions for Coverage. CMS and its state survey agencies evaluate whether providers meet those conditions. Payment from Medicare/Medicaid ordinarily requires ongoing compliance. Failure can lead to deficiency findings, plans of correction, civil money penalties, denial of payment, or termination from the program.

Accreditation is typically granted by a private accrediting organization (for example, The Joint Commission, DNV, HFAP/ACHC pathways depending on setting) after standards-based evaluation. Accreditation supports quality branding, payer contracting, and—critically— deemed status when CMS has approved the accreditor’s program: CMS may “deem” an accredited hospital to meet Medicare CoPs, reducing (not eliminating) the need for routine CMS surveys. Deemed status is a privilege contingent on performance; CMS retains authority to conduct validation surveys, complaint investigations, and immediate-jeopardy responses.

Executives must keep three truths simultaneous: (1) accreditation does not replace state licensure; (2) accreditation does not immunize against OSHA, FDA, NRC, EPA, or state fire marshal enforcement; (3) “passing survey” is not the same as a culture of continuous compliance.

Authority Primary purpose Typical enforcer Executive takeaway

State licensure Legal permission to operate regulated facilities/services State health department or licensing board Required independently of accreditation or CMS participation

Medicare CoPs / certification Federal conditions for program participation and payment CMS and state survey agencies Deficiencies can threaten payment, impose CMPs, or end participation

Accreditation / deemed status Standards-based evaluation; may deem CoPs met Private accreditors (e.g., TJC, DNV) Supports quality branding and surveys; never replaces licensure

OSHA Workplace safety and health for workers OSHA or OSHA state plans Injury, PPE, bloodborne, violence, and training accountability

FDA Drugs, devices, biologics/blood, certain food interfaces FDA Recalls, device reporting, compounding, investigational products

NRC / Agreement States Civilian radioactive materials programs NRC or Agreement State agency RSO, source security, dose monitoring, continuous license conditions

CMS Conditions of Participation and Survey Logic

CoPs address core hospital functions: governing body, medical staff, nursing services, quality assessment and performance improvement (QAPI), medical records, infection control, pharmaceutical services, emergency services, discharge planning, patients’ rights, and more. Surveyors look for policies, implementation evidence, staff competency, and outcomes —not binder theater. Immediate jeopardy findings signal a high likelihood of serious harm and force rapid executive attention, 24/7 resource deployment, and documented abatement.

A mature executive model treats survey readiness as always-on : tracers that follow the patient journey, environment-of-care rounding, infection prevention audits, privilege and credentialing integrity, restraint/seclusion documentation, and closed-loop corrective action after adverse events. Boards should receive trend dashboards on survey risk domains, not only post-survey debriefs.

OSHA: Worker Safety as Organizational Duty

The Occupational Safety and Health Administration (OSHA) enforces workplace safety and health standards applicable to most private-sector employers and many public employers under state plans. Healthcare OSHA priorities commonly include bloodborne pathogens, hazard communication, respiratory protection, workplace violence prevention expectations evolving through enforcement and guidance, sharps injury logs, TB exposure control where applicable, and general duty clause cases when recognized hazards lack specific standards.

For FACHE leaders, OSHA is both legal compliance and talent strategy. High injury rates, needlestick clusters, and violence incidents drive workers’ compensation cost, turnover, union activity, and reputation risk. Executives should ensure: written programs; training with competency validation; personal protective equipment (PPE) availability; engineering controls (safer sharps, lift equipment); reporting without retaliation; and integration with infection prevention and security. Multi-site systems need consistent standards with local adaptation and centralized incident analytics.

FDA: Drugs, Devices, Blood, and Food Safety Interfaces

The Food and Drug Administration (FDA) regulates drugs, biologics, medical devices, blood and tissue products, and certain aspects of food safety relevant to hospital dietary and retail operations. Hospitals encounter FDA risk through pharmacy compounding and distribution practices, investigational product handling, medical device reporting (MDR) obligations for device-related deaths/serious injuries, recalls and field corrective actions, radiation-emitting equipment (with other agencies depending on modality), and clinical research involving FDA-regulated products.

Executives do not run the pharmacy day to day, but they own the control environment: who is accountable for recall response time, how device failures escalate to risk management and reporting, whether 503A/503B compounding arrangements are legally structured, and whether research sites have institutional review board (IRB) and investigational drug accountability processes. A delayed recall pull or unreported device death can become a regulatory event and a plaintiff narrative simultaneously.

NRC and Radiation Safety Oversight

The Nuclear Regulatory Commission (NRC) (and Agreement State agencies that assume NRC authority) regulates civilian use of nuclear materials, including many nuclear medicine and radiation therapy materials under specific licenses. Hospitals with radioactive materials programs need radiation safety officers (RSOs), written radiation protection programs, dose monitoring, security of sources, training, and event reporting. Linacs and imaging may also intersect state radiation control programs and FDA equipment rules.

Executive implications include capital planning for replacement of aging sources/equipment, contingency for source security, credentialing of authorized users, and ensuring the RSO has independence and access to leadership when safety conflicts with throughput pressure.

CDC: Guidance, Not Always Binding—But Operationally Decisive

The Centers for Disease Control and Prevention (CDC) issues evidence-based guidance on infection control, vaccination, outbreak response, and public health surveillance. CDC guidance is often not a freestanding “license condition,” yet it becomes operationally decisive when adopted into CMS expectations, state rules, Joint Commission elements of performance, payer quality programs, or professional standards of care. During outbreaks, executives rely on CDC (and state health departments) for isolation precautions, PPE strategies, testing algorithms, and reporting.

Leaders should formalize how guidance is triaged into policy : infection prevention committee review, medical staff endorsement where practice changes, rapid communication, supply chain alignment, and documentation of the version of guidance in force. Inconsistent local “custom practices” without a documented decision trail create liability when harm occurs.

State and Multi-Agency Inspection Reality

State survey agencies often perform Medicare certification surveys under agreement with CMS and conduct state licensure surveys. Fire marshals, pharmacy boards, professional licensing boards, CLIA for laboratories, DEA for controlled substances, EPA for hazardous waste, and local building authorities add parallel oversight. Executives need a regulatory inventory : which agencies, which sites, which licenses/certificates, renewal calendars, and who is the accountable owner for each.

Complaint investigations and media-driven scrutiny often trigger focused surveys. A single never-event can bring simultaneous CMS, state, accreditor, OSHA (if worker involved), and plaintiff activity. Incident command-style coordination among quality, risk, legal, communications, and operations reduces contradictory statements and missed deadlines for plans of correction.

Building an Integrated Readiness System

High-performing organizations: map standards to owners; run continuous tracers; maintain accurate privilege and competency files; harden environment of care (utilities, medical equipment, life safety); treat infection prevention as a core operating system; close corrective actions with effectiveness checks; and brief the board on residual risk. Accreditation “scores” matter less than whether leaders can honestly answer: Would we be proud of this process if surveyors arrived today—and would patients be safer for it?

Executive Decision Lens

When evaluating a service line expansion, construction project, or new technology, ask: What licenses or certificates are required? Which CoPs or accreditation standards change? Do OSHA, FDA, NRC, or radiation control obligations expand? Who owns continuous readiness budget and staffing? How will we evidence compliance? Accreditation and inspection competence is strategic capacity—without it, strategy is only a press release until the next survey or complaint.